Amicus Therapeutics Inc. buy Citigroup Inc.
Start price
17.12.25
/
50%
€9.40
Target price
17.12.26
€14.47
Performance (%)
-1.60%
Price
17.12.25
€9.20
Summary
This prediction is currently active. With a performance of -1.60%, the BUY prediction by Citigroup_Inc_ is trending in the wrong direction. This prediction currently runs until 17.12.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Amicus Therapeutics Inc. | -1.60% |
| iShares Core DAX® | -1.212% |
| iShares Nasdaq 100 | -4.714% |
| iShares Nikkei 225® | -2.976% |
| iShares S&P 500 | -2.744% |
Comments by Citigroup_Inc_ for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics (NASDAQ:FOLD) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $17.00 price target on the stock.
Ratings data for FOLD provided by MarketBeat